Drugs / autologous muscle precursor cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT05534269 | Oct 2022 → Jul 2025 | female stress incontinence | University of Zurich | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | autologous muscle precursor cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05534269 ↗ |
| Modality | Cell therapy | “the cell therapy” NCT05534269 ↗ |
| Route | Intramuscular | “injected into the rhabdomyosphincter” NCT05534269 ↗ |